+499.5%
MRNA vs NVDX
+34.6%
+464.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NVDX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.4% | -3.7% | -2.2% |
| 7D | +5.5% | +11.6% | -6.1% | +5.5% |
| 30D | +158.7% | +7.5% | +151.2% | +159.2% |
| 3M | +182.1% | +2.1% | +180.0% | +184.8% |
| 6M | +151.8% | +35.5% | +116.3% | +144.8% |
| YTD | +393.6% | +24.1% | +369.4% | +378.4% |
| 1Y | +499.5% | +33.0% | +466.5% | +461.4% |
| All | +499.5% | +34.6% | +464.9% | +461.4% |
Cumulative growth
Daily Returns
Daily percentage return beside NVDX.
Daily Out/Under-Performance
Portfolio return minus NVDX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVDX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NVDX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling